253 related articles for article (PubMed ID: 34974168)
21. Sensitive western blotting for detection of endogenous Ser129-phosphorylated α-synuclein in intracellular and extracellular spaces.
Sasaki A; Arawaka S; Sato H; Kato T
Sci Rep; 2015 Sep; 5():14211. PubMed ID: 26381815
[TBL] [Abstract][Full Text] [Related]
22. Alpha-Synuclein as a Biomarker for Parkinson's Disease.
Atik A; Stewart T; Zhang J
Brain Pathol; 2016 May; 26(3):410-8. PubMed ID: 26940058
[TBL] [Abstract][Full Text] [Related]
23. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
[TBL] [Abstract][Full Text] [Related]
24. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
Vivacqua G; Suppa A; Mancinelli R; Belvisi D; Fabbrini A; Costanzo M; Formica A; Onori P; Fabbrini G; Berardelli A
Parkinsonism Relat Disord; 2019 Jun; 63():143-148. PubMed ID: 30796010
[TBL] [Abstract][Full Text] [Related]
25. Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein.
Waxman EA; Giasson BI
J Neuropathol Exp Neurol; 2008 May; 67(5):402-16. PubMed ID: 18451726
[TBL] [Abstract][Full Text] [Related]
26. Plasma TNF-α and phosphorylated α-syn are associated with fatigue in patients with Parkinson's disease.
Wang L; Yi H; Liang X; Xu F; Li T; Yang X; Wei M; Ou Z; Tong Q
J Neuroimmunol; 2023 Dec; 385():578222. PubMed ID: 37918213
[TBL] [Abstract][Full Text] [Related]
27. Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.
Heinzel S; Gold M; Deuschle C; Bernhard F; Maetzler W; Berg D; Dodel R
PLoS One; 2014; 9(12):e114566. PubMed ID: 25470145
[TBL] [Abstract][Full Text] [Related]
28. High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
Bougea A; Stefanis L; Emmanouilidou E; Vekrelis K; Kapaki E
J Neural Transm (Vienna); 2020 Mar; 127(3):311-322. PubMed ID: 31912280
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates.
Arawaka S; Sato H; Sasaki A; Koyama S; Kato T
Acta Neuropathol Commun; 2017 Jun; 5(1):48. PubMed ID: 28619113
[TBL] [Abstract][Full Text] [Related]
30. The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease.
Garg P; Maass F; Sundaram SM; Mollenhauer B; Mahajani S; van Riesen C; Kügler S; Bähr M
Mol Cell Neurosci; 2022 Jul; 121():103746. PubMed ID: 35660088
[TBL] [Abstract][Full Text] [Related]
31. Alpha-Synuclein Accumulation and Its Phosphorylation in the Enteric Nervous System of Patients Without Neurodegeneration: An Explorative Study.
Bu LL; Huang KX; Zheng DZ; Lin DY; Chen Y; Jing XN; Liang YR; Tao EX
Front Aging Neurosci; 2020; 12():575481. PubMed ID: 33328957
[TBL] [Abstract][Full Text] [Related]
32. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.
Dutta S; Hornung S; Kruayatidee A; Maina KN; Del Rosario I; Paul KC; Wong DY; Duarte Folle A; Markovic D; Palma JA; Serrano GE; Adler CH; Perlman SL; Poon WW; Kang UJ; Alcalay RN; Sklerov M; Gylys KH; Kaufmann H; Fogel BL; Bronstein JM; Ritz B; Bitan G
Acta Neuropathol; 2021 Sep; 142(3):495-511. PubMed ID: 33991233
[TBL] [Abstract][Full Text] [Related]
33. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
[TBL] [Abstract][Full Text] [Related]
34. Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease.
Ma LY; Gao LY; Li X; Ma HZ; Feng T
Neurosci Lett; 2019 Jun; 704():45-49. PubMed ID: 30946930
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
Parnetti L; Chiasserini D; Bellomo G; Giannandrea D; De Carlo C; Qureshi MM; Ardah MT; Varghese S; Bonanni L; Borroni B; Tambasco N; Eusebi P; Rossi A; Onofrj M; Padovani A; Calabresi P; El-Agnaf O
Mov Disord; 2011 Jul; 26(8):1428-35. PubMed ID: 21469206
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.
Foulds PG; Mitchell JD; Parker A; Turner R; Green G; Diggle P; Hasegawa M; Taylor M; Mann D; Allsop D
FASEB J; 2011 Dec; 25(12):4127-37. PubMed ID: 21865317
[TBL] [Abstract][Full Text] [Related]
37. Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.
Buck K; Landeck N; Ulusoy A; Majbour NK; El-Agnaf OM; Kirik D
Neurobiol Dis; 2015 Jun; 78():100-14. PubMed ID: 25818009
[TBL] [Abstract][Full Text] [Related]
38. A FRET-based aptasensor for the detection of α-synuclein oligomers as biomarkers of Parkinson's disease.
Saedi Z; Nikkhah M
Anal Methods; 2022 Aug; 14(30):2937-2944. PubMed ID: 35861142
[TBL] [Abstract][Full Text] [Related]
39. The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature.
Simonsen AH; Kuiperij B; El-Agnaf OM; Engelborghs S; Herukka SK; Parnetti L; Rektorova I; Vanmechelen E; Kapaki E; Verbeek M; Mollenhauer B
Biomark Med; 2016; 10(1):19-34. PubMed ID: 26314196
[TBL] [Abstract][Full Text] [Related]
40. Lewy Body-Associated Proteins A-Synuclein (a-syn) as a Plasma-Based Biomarker for Parkinson's Disease.
Zhao X; He H; Xiong X; Ye Q; Feng F; Zhou S; Chen W; Xia K; Qian S; Yang Y; Xie C
Front Aging Neurosci; 2022; 14():869797. PubMed ID: 35645787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
